This article was initially an anchor piece; in February 2019 however, it was moved and completely revised into “CRISPR gene editing”.
Wave genetics suggests that DNA can be affected and controlled by electromagnetic waves such as sound or light frequencies. While much research has been conducted into this theory, its full implications remain unexplored and poorly understood.
What is wave genetics?
Wave genetics is a theory which proposes that DNA can be altered and controlled through electromagnetic waves, while these electromagnetic waves carry information which will pass down generations. Research in this area continues, yet its potential is tremendous and could revolutionize genetics research as we know it today.
This theory rests on the notion that all matter interactions occur as waves in space rather than discrete particles as we currently believe. Additionally, it proposes that DNA may be affected and controlled through sound and light frequencies; this could improve genetic engineering by enabling us to alter gene expression levels more precisely.
Researchers recently utilized linguistic-wave genetics to regenerate a dog tooth using quantum genes based on spintronic principles – marking an impressive milestone and opening up this revolutionary new field in biology. Their discovery may also prove useful in treating genetic disorders or creating new medicines.
How does wave genetics work?
DNA is more than a chemical structure; it also acts as an electromagnetic generator, emitting and receiving waves of information that can be controlled with specific frequencies of electromagnetic waves (including sound and light frequencies) such as sound genetics. Wave genetics is an evolving theory which suggests we can use these frequencies to communicate with and influence the behavior of our DNA.
This theory is founded upon the notion that all matter interactions occur as waves in space rather than discrete particles, as in our current model of matter and its interactions. Furthermore, DNA contains quantum memories which store and transmit information between generations.
Researchers used a Helium-Neon laser with two orthogonal optical modes to transfer quantum genetic information into a crude form of dog’s teeth. This information then spontaneously transformed into modulated broadband electromagnetic radiation carrying its original genetic code; its return back home could then be recorded through probe photon polarization modulation states when returning back into their resonators.
Results from this experiment were impressive, yet more research needs to be conducted in order to fully realize wave genetics‘ full potential. Wave genetics has the potential to treat genetic diseases, improve crop yields, and create novel methods of genetic engineering – however it should be remembered that wave genetics isn’t intended to replace traditional gene therapy methods; rather it provides another tool which can enhance their effectiveness by being combined with traditional therapies.
What are the potential applications of wave genetics?
This cutting-edge science theory suggests that DNA is not simply chemical in its makeup, but also an electromagnetic generator. This means the information stored within genes can be altered and controlled through specific frequencies of electromagnetic waves. Wave genetics has several applications; including treating genetic diseases and reprogramming cells – in fact, researchers have used wave genetics successfully regenerating a dog tooth!
Research was carried out using a frequency-stabilized Helium-Neon laser that produces both linear and chiral harmonic modes of light, then recorded on a photomultiplier tube and analyzed with a high-resolution spectrometer. Results show that human DNA could be transferred onto dog’s teeth using this method; an important step toward gene therapy, as it indicates how DNA molecules may be controlled externally through sound or light frequencies.
Current genetic diseases are treated by replacing mutant genes with regular ones through genome editing, but this process can be costly and difficult in large populations. According to this research team’s assessment, wave genetics might offer an effective and less expensive alternative for treating genetic conditions.
By employing both computational tools and experimental measurements, scientists were able to pinpoint the frequency of electromagnetic waves needed to alter a cell’s genetic code and cause mutations within. Once introduced into other cells, these mutations lead to mutations as well.
The team’s findings demonstrate the numerous potential applications of wave genetics, from disease prevention and drug discovery, to consumer behavior theory refinement and strengthening. Genetic data could even help predict consumer responses to specific products – which would allow marketers to better target marketing campaigns and boost product sales.
Where can I find more information about wave genetics?
Wave genetics is an alternative approach to traditional genetics that utilizes electromagnetic waves as a tool to influence and manipulate DNA. According to this theory, DNA acts not just as a chemical structure but also an electromagnetic generator emitting and receiving electromagnetic waves which carry information for future generations. Note that research on this theory continues and remains incompletely understood.
Wave genetics aims to develop a more comprehensive understanding of genome function. From this information can come new methods for editing genes which could ultimately treat genetic disorders or improve crop yields. Though much work remains, wave genetics is an exciting field with immense potential that has the power to transform how we understand DNA.
Wave Life Sciences, a clinical-stage genetic medicines company dedicated to developing life-changing treatments for devastating diseases, announced a strategic collaboration with GSK plc today to advance oligonucleotide therapeutics. The initial four-year discovery collaboration brings together GSK’s unique insights in human genetics with Wave’s proprietary discovery and drug development platform called PRISM; under the agreement GSK will gain exclusive global rights for Wave’s preclinical RNA editing program called WVE-006 that uses their AIMer technology.
WVE-006, an investigational development candidate modified with PN chemistry and GalNAc conjugated, aims to address both liver and lung symptoms associated with AATD. Wave plans on filing clinical trial applications for WVE-006 by early 2023.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements relate to future events or anticipated financial performance of the Company, such as expectations regarding its development, manufacture and commercialization of oligonucleotide therapeutics under GSK partnership. Such forward-looking statements reflect current beliefs and assumptions by its management as well as risks that could cause actual results to differ materially from projected or implied ones.
